Aptose Bioscns (APTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APTO | BMY | AMGN | GILD | VRTX |
| Company | Aptose Bioscns | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.7456 | 72.11 | 253.86 | 83.52 | 319.98 |
| High | 0.7600 | 72.66 | 253.86 | 84.21 | 325.19 |
| Low | 0.7400 | 71.65 | 249.89 | 83.22 | 319.98 |
| Last | 0.7500 | 72.65 | 252.40 | 83.94 | 323.10 |
| Change | +0.0091 | +0.62 | +0.81 | +0.59 | +3.12 |
| % Change | +1.23% | +0.86% | +0.32% | +0.71% | +0.98% |
| Volume | 368,700 | 9,375,200 | 3,418,300 | 9,621,700 | 1,352,900 |
| 20-Day Average Volume | 272,985 | 8,242,260 | 2,171,600 | 6,305,575 | 1,460,155 |
| Previous Close | 0.7409 | 72.03 | 251.59 | 83.35 | 319.98 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.6769 | 72.49 | 263.82 | 84.90 | 303.91 |
| 20-Day Raw Stochastic | 94.44% | 44.71% | 9.31% | 29.61% | 95.14% |
| 20-Day Relative Strength | 62.04% | 46.06% | 35.25% | 48.93% | 63.42% |
| Weighted Alpha | -42.77 | +6.60 | +9.30 | +37.60 | +33.40 |
| Today's Opinion | 24% Buy | 40% Sell | 8% Sell | 40% Buy | 88% Buy |
| Previous Opinion | 24% Buy | 56% Sell | 8% Sell | 40% Buy | 88% Buy |
| Last Month's Opinion | 100% Sell | 24% Sell | 40% Buy | 80% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.87% since 01/24/23 | +0.43% since 01/24/23 | -2.81% since 01/24/23 | -0.10% since 01/24/23 | +3.04% since 01/24/23 |
| Low | 0.6901 on 01/25/23 | 71.65 on 01/31/23 | 249.89 on 01/31/23 | 82.33 on 01/30/23 | 312.00 on 01/25/23 |
| High | 0.7600 on 01/31/23 | 73.45 on 01/27/23 | 261.55 on 01/25/23 | 84.55 on 01/25/23 | 325.19 on 01/31/23 |
| 1-Month | |||||
| %Chg | +29.31% since 12/30/22 | +0.97% since 12/30/22 | -3.90% since 12/30/22 | -2.22% since 12/30/22 | +11.88% since 12/30/22 |
| Low | 0.5800 on 01/04/23 | 70.75 on 01/09/23 | 249.89 on 01/31/23 | 82.11 on 01/24/23 | 282.21 on 01/09/23 |
| High | 0.7600 on 01/31/23 | 75.00 on 01/24/23 | 276.84 on 01/11/23 | 88.29 on 01/06/23 | 325.19 on 01/31/23 |
| 3-Month | |||||
| %Chg | +62.87% since 10/31/22 | -6.22% since 10/31/22 | -6.64% since 10/31/22 | +6.98% since 10/31/22 | +3.56% since 10/31/22 |
| Low | 0.4255 on 12/27/22 | 70.75 on 01/09/23 | 249.89 on 01/31/23 | 77.16 on 11/03/22 | 282.21 on 01/09/23 |
| High | 0.7900 on 11/08/22 | 81.43 on 12/01/22 | 296.67 on 11/08/22 | 89.74 on 12/13/22 | 325.19 on 01/31/23 |
| 6-Month | |||||
| %Chg | +1.06% since 07/29/22 | -1.53% since 07/29/22 | +1.99% since 07/29/22 | +40.49% since 07/29/22 | +15.22% since 07/29/22 |
| Low | 0.4255 on 12/27/22 | 65.95 on 08/30/22 | 223.30 on 09/22/22 | 59.27 on 08/01/22 | 271.61 on 08/03/22 |
| High | 0.9200 on 08/08/22 | 81.43 on 12/01/22 | 296.67 on 11/08/22 | 89.74 on 12/13/22 | 325.19 on 01/31/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 68,381 | 153,147,296 | 134,243,136 | 104,541,240 | 82,135,992 |
| Shares Outstanding, K | 92,295 | 2,126,160 | 533,579 | 1,254,244 | 256,691 |
| Annual Sales | 0 | 46,385,000,000 | 25,979,000,000 | 27,305,000,000 | 7,574,400,000 |
| Annual Net Income | -65,350,000 | 6,994,000,000 | 5,893,000,000 | 6,225,000,000 | 2,342,100,000 |
| Last Quarter Sales | 0 | 11,218,000,000 | 6,652,000,000 | 7,042,000,000 | 2,334,300,000 |
| Last Quarter Net Income | -9,777,000 | 1,606,000,000 | 2,143,000,000 | 1,789,000,000 | 930,500,000 |
| 60-Month Beta | 1.47 | 0.44 | 0.67 | 0.45 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.11 on 11/01/22 | 1.99 on 10/25/22 | 4.70 on 11/03/22 | 1.90 on 10/27/22 | 4.01 on 10/27/22 |
| Latest Earnings Date | 11/01/22 | 02/02/23 | 01/31/23 | 02/02/23 | 02/07/23 |
| Most Recent Dividend | N/A | 0.570 on 01/05/23 | 1.940 on 11/16/22 | 0.730 on 12/14/22 | N/A |
| Next Ex-Dividends Date | N/A | 01/05/23 | 02/14/23 | 12/14/22 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 9.40 | 14.12 | 13.31 | 24.33 |
